Sonnet Biotherapeutics Holdings Inc. buy Chardan Capital
Start price
07.04.25
/
50%
€0.18
Target price
07.04.26
€18.22
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 07.04.26. The prediction end date can be changed by Chardan_Capital at any time.Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Sonnet Biotherapeutics Holdings Inc. | - | - |
| iShares Core DAX® | 0.734% | 1.458% |
| iShares Nasdaq 100 | -2.686% | -0.146% |
| iShares Nikkei 225® | -2.261% | -2.729% |
| iShares S&P 500 | -1.346% | 0.467% |
Comments by Chardan_Capital for this prediction
In the thread Sonnet Biotherapeutics Hldgs. Inc. diskutieren
Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $20.00 price target on the stock.
Ratings data for SONN provided by MarketBeat
Stopped prediction by Chardan_Capital for Sonnet Biotherapeutics Holdings Inc.
Sonnet Biotherapeutics Holdings Inc.
Start price
Target price
Perf. (%)
€0.18
28.03.25
28.03.25
€18.53
28.03.26
28.03.26
-
20.11.23
20.11.23
Sonnet Biotherapeutics Holdings Inc.
Start price
Target price
Perf. (%)
€0.18
20.12.24
20.12.24
€19.21
20.12.25
20.12.25
-
20.11.23
20.11.23
Sonnet Biotherapeutics Holdings Inc.
Start price
Target price
Perf. (%)
€0.18
23.08.24
23.08.24
€26.85
23.08.25
23.08.25
-
24.08.25
24.08.25
Sonnet Biotherapeutics Holdings Inc.
Start price
Target price
Perf. (%)
€0.18
28.05.24
28.05.24
€27.57
28.05.25
28.05.25
-
29.05.25
29.05.25
Sonnet Biotherapeutics Holdings Inc.
Start price
Target price
Perf. (%)
€0.18
15.02.24
15.02.24
€27.86
15.02.25
15.02.25
-
16.02.25
16.02.25
Sonnet Biotherapeutics Holdings Inc.
Start price
Target price
Perf. (%)
€0.38
16.08.23
16.08.23
€11.00
16.08.24
16.08.24
-51.06%
17.08.24
17.08.24

